300314.SZ
Ningbo David Medical Device Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 12.45
−5.03%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 575.7M | 584.0M | 527.0M | 618.3M | 506.0M |
| Cost of Revenue | 275.4M | 270.9M | 229.4M | 262.5M | 209.7M |
| Gross Profit | 300.2M | 313.2M | 297.6M | 355.8M | 296.3M |
| Operating Expenses | |||||
| R&D Expense | 55.9M | 59.3M | 55.5M | 48.1M | 45.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 74.0M | 73.8M | 64.9M | 54.2M | 43.6M |
| Selling & Marketing Expense | 98.4M | 101.0M | 107.6M | 117.9M | 111.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 236.1M | 235.5M | 224.1M | 209.1M | 187.2M |
| Cost and Expenses | 511.6M | 506.4M | 453.5M | 471.6M | 397.0M |
| Operating Income (EBIT) | 84.4M | 98.6M | 68.8M | 171.4M | 112.0M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 84.1M | 98.7M | 63.4M | 166.2M | 111.9M |
| Income Tax Expense | 9.7M | 11.6M | 6.1M | 18.6M | 14.6M |
| Bottom Line | |||||
| Net Income | 74.4M | 87.1M | 57.3M | 147.6M | 97.4M |
| Earnings from Cont. Ops | 74.4M | 87.1M | 57.3M | 147.6M | 97.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 74.4M | 87.1M | 57.3M | 147.6M | 97.4M |
| Per Share | |||||
| Basic EPS | CN¥0.26 | CN¥0.30 | CN¥0.20 | CN¥0.51 | CN¥0.34 |
| Diluted EPS | CN¥0.26 | CN¥0.30 | CN¥0.20 | CN¥0.51 | CN¥0.34 |
| Revenue Per Share | CN¥2.00 | CN¥2.01 | CN¥1.84 | CN¥2.14 | CN¥1.77 |
| Shares | |||||
| Basic Shares Outstanding | 288.2M | 290.2M | 286.3M | 289.4M | 286.3M |
| Diluted Shares Outstanding | 288.2M | 290.2M | 286.3M | 289.4M | 286.3M |
| Profitability Metrics | |||||
| EBITDA | — | 125.4M | 96.6M | 198.8M | 135.4M |
| D&A | — | 26.7M | 27.9M | 27.4M | 23.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026